Edyta Pawlak-Adamska

Edyta Pawlak-Adamska

UNVERIFIED PROFILE

Are you Edyta Pawlak-Adamska?   Register this Author

Register author
Edyta Pawlak-Adamska

Edyta Pawlak-Adamska

Publications by authors named "Edyta Pawlak-Adamska"

Are you Edyta Pawlak-Adamska?   Register this Author

24Publications

429Reads

48Profile Views

Regulation of signaling pathways by Ampelopsin (Dihydromyricetin) in different cancers: exploring the highways and byways less travelled.

Cell Mol Biol (Noisy-le-grand) 2019 Sep 30;65(7):15-20. Epub 2019 Sep 30.

Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.

View Article

Download full-text PDF

Source
September 2019

Urinary tract infections (UTIs) or genital tract infections (GTIs)? It's the diagnostics that count.

GMS Hyg Infect Control 2019 18;14:Doc14. Epub 2019 Feb 18.

Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3205/dgkh000320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449866PMC
February 2019

Epitopes identified in GAPDH from Clostridium difficile recognized as common antigens with potential autoimmunizing properties.

Sci Rep 2018 09 17;8(1):13946. Epub 2018 Sep 17.

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Department of Immunology of Infectious Diseases, Laboratory of Medical Microbiology, Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-32193-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141484PMC
September 2018

The Influence of Genetic Variations in the Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

J Immunol Res 2018 7;2018:3826989. Epub 2018 Feb 7.

Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, R Weigl 12, 53-114 Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/3826989DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821961PMC
August 2018

Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study.

Brain Behav Immun 2018 07 3;71:28-36. Epub 2018 May 3.

Department of Genetics, Wroclaw Medical University, Marcinkowskiego 1 Street, 50-368 Wroclaw, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbi.2018.05.002DOI Listing
July 2018

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.

Endocrine 2017 Jan 16;55(1):186-199. Epub 2016 Sep 16.

Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, L. Pasteur 4, Wroclaw, 50-367, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-016-1096-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225215PMC
January 2017

Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.

J Neuroimmunol 2015 Nov 18;288:79-86. Epub 2015 Sep 18.

Laboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, |Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, ul. Weigla 12, 53-114 Wrocław, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2015.09.004DOI Listing
November 2015

A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.

Immunogenetics 2015 Jun 5;67(5-6):295-304. Epub 2015 May 5.

Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, Polish Academy of Science, R. Weigl 12, 53-114, Wroclaw, Poland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00251-015-0840-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427628PMC
June 2015

Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation.

Immunol Lett 2015 May 1;165(1):52-9. Epub 2015 Apr 1.

Department of Experimental Therapy, L. Hirszfeld Institute of Immunology & Experimental Therapy, R Weigl St 12, Wroclaw 53-114, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2015.03.011DOI Listing
May 2015

[The role of adipose tissue in the pathogenesis and clinical manifestation of Graves' orbitopathy].

Postepy Hig Med Dosw (Online) 2013 Dec 2;67:1173-81. Epub 2013 Dec 2.

Katedra i Klinika Endokrynologii, Diabetologii i Leczenia Izotopami, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/17322693.1078402DOI Listing
December 2013

PPARg2 Ala¹² variant protects against Graves' orbitopathy and modulates the course of the disease.

Immunogenetics 2013 Jul 21;65(7):493-500. Epub 2013 Apr 21.

Department of Experimental Therapy, L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, R. Weigla 12, 53-114 Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00251-013-0702-0DOI Listing
July 2013